Search

Your search keyword '"Farina, Nicolas"' showing total 25 results
Start Over Author "Farina, Nicolas" Publisher wiley
25 results on '"Farina, Nicolas"'

1. Awareness, attitudes, and beliefs of dementia in Indonesia

Author

Farina, Nicolas, primary, Hassan, Esra, additional, Theresia, Imelda, additional, Fitri, Fasihah Irfani, additional, Suswanti, Ika, additional, Sani, Tara Puspitarini, additional, Evans‐Lacko, Sara, additional, Banerjee, Sube, additional, and Turana, Yuda, additional

Published
2024
Full Text
View/download PDF

7. Investigating the social and environmental contexts of habitual walking ACTIVities in older adult DYADs: A mixed methods protocol for the ActivDyad study

Author

Ardle, Ríona Mc, primary, Ryan, Leigh James, additional, McCarthy, Louis, additional, Wilson, Cameron, additional, Hamilton, Calum Alexander, additional, Tangen, Gro Gujord, additional, Farina, Nicolas, additional, Ireson, Neil, additional, Lanfranchi, Vita, additional, Hicks, Ben, additional, and Bayat, Sayeh, additional

Published
2023
Full Text
View/download PDF

8. Description of the cross‐cultural process adopted in the STRiDE (STrengthening Responses to dementia in DEveloping countries) program: A methodological overview

Author

Farina, Nicolas, primary, Jacobs, Roxanne, additional, Sani, Tara Puspitarini, additional, Schneider, Marguerite, additional, Theresia, Imelda, additional, Turana, Yuda, additional, Fitri, Fasihah Irfani, additional, Albanese, Emiliano, additional, Lorenz‐Dant, Klara, additional, Docrat, Sumaiyah, additional, Toit, Petra Du, additional, Ferri, Cleusa P., additional, Govia, Ishtar, additional, Comas‐Herrera, Adelina, additional, Ibnidris, Aliaa, additional, Knapp, Martin, additional, and Banerjee, Sube, additional

Published
2022
Full Text
View/download PDF

10. A comparative study of the effect of the Time for Dementia programme on medical students

Author

Banerjee, Sube, primary, Jones, Christopher, additional, Wright, Juliet, additional, Grosvenor, Wendy, additional, Hebditch, Molly, additional, Hughes, Leila, additional, Feeney, Yvonne, additional, Farina, Nicolas, additional, Mackrell, Sophie, additional, Nilforooshan, Ramin, additional, Fox, Chris, additional, Bremner, Stephen, additional, and Daley, Stephanie, additional

Published
2021
Full Text
View/download PDF

12. DETERMinants of quality of life, care and costs, and consequences of INequalities in people with Dementia and their carers (DETERMIND): A protocol paper

Author

Farina, Nicolas, primary, Hicks, Ben, additional, Baxter, Kate, additional, Birks, Yvonne, additional, Brayne, Carol, additional, Dangoor, Margaret, additional, Dixon, Josie, additional, Harris, Peter R., additional, Hu, Bo, additional, Knapp, Martin, additional, Miles, Eleanor, additional, Perach, Rotem, additional, Read, Sanna, additional, Robinson, Louise, additional, Rusted, Jennifer, additional, Stewart, Rob, additional, Thomas, Alan, additional, Wittenberg, Raphael, additional, and Banerjee, Sube, additional

Published
2019
Full Text
View/download PDF

15. How do we enhance undergraduate healthcare education in dementia? A review of the role of innovative approaches and development of the Time for Dementia programme

Author

Banerjee, Sube, Farina, Nicolas, Daley, Stephanie, Grosvenor, Wendy, Hughes, Leila, Hebditch, Molly, Mackrell, Sophie, Nilforooshan, Ramin, Wyatt, Chris, de Vries, Kay, Haq, Inam, and Wright, Juliet

Subjects
multi‐morbidity, Health Personnel, long‐term conditions, education, healthcare education, R735, Review Article, Alzheimer's disease, R1, senior mentorship programme, senior mentorship, longitudinal integrated clerkship, Humans, Dementia, interdisciplinary learning, Curriculum, Review Articles, Delivery of Health Care, Alzheimer’s disease, dementia
Abstract

The file attached to this record is the author's final version. The Publisher's final version can be found by following the DOI link. Open access article Traditional healthcare education, delivered through a series of time-limited clinical placements, often fails to deliver an understanding of the experiences of those with long-term conditions, a growing issue for healthcare systems. Responses include longitudinal integrated clerkships and senior mentor programmes allowing students’ longer placements, continuity of contact and opportunities to learn about chronic illness and patient experience. We review their development and delivery in dementia and present the Time for Dementia (TFD) Programme, a novel 2-year interdisciplinary educational programme. Design: The study design involves a scoping review of enhanced placements in dementia for healthcare professionals in training including longitudinal integrated clerkships and senior mentor programmes and a case study of the development of TFD and its evaluation. Results: Eight enhanced programmes in dementia were identified and seven in the USA. None were compulsory and all lasted 12 months. All reported positive impact from case study designs but data quality was weak. Building on these, TFD was developed in partnership between the Alzheimer’s Society, universities and NHS and made a core part of the curriculum for medical, nursing and paramedic students. Students visit a person with dementia and their family in pairs for 2 h every 3 months for 2 years. They follow a semi-structured interaction guide focusing on experiences of illness and services and complete reflective appraisals. Conclusions: We need interprofessional undergraduate healthcare education that enables future healthcare professionals to be able to understand and manage the people with the long-term conditions who current systems often fail. TFD is designed to help address this need.

Published
2016

25. Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Author

Farina N, Isaac MG, Clark AR, Rusted J, and Tabet N

Subjects
Disease Progression, Humans, Outcome Assessment, Health Care, Randomized Controlled Trials as Topic, Alzheimer Disease drug therapy, Antioxidants therapeutic use, Cognitive Dysfunction drug therapy, Vitamin E therapeutic use
Abstract

Background: Vitamin E is a dietary compound that functions as an antioxidant scavenging toxic free radicals. Evidence that free radicals may contribute to the pathological processes of cognitive impairment including Alzheimer's disease has led to interest in the use of vitamin E in the treatment of mild cognitive impairment (MCI) and Alzheimer's dementia (AD)., Objectives: To assess the efficacy of vitamin E in the treatment of AD and prevention of progression of MCI to dementia., Search Methods: The Specialized Register of the Cochrane Dementia and Cognitive Improvement Group (ALOIS), The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL, LILACS as well as many trials databases and grey literature sources were searched on 25 June 2012 using the terms: "Vitamin E", vitamin-E, alpha-tocopherol., Selection Criteria: All unconfounded, double-blind, randomised trials in which treatment with vitamin E at any dose was compared with placebo for patients with AD and MCI., Data Collection and Analysis: Two review authors independently applied the selection criteria and assessed study quality and extracted and analysed the data. For each outcome measure data were sought on every patient randomised. Where such data were not available an analysis of patients who completed treatment was conducted. It was not possible to pool data between studies owing to a lack of comparable outcome measure., Main Results: Only three studies met the inclusion criteria: two in an AD population and one in an MCI population. In the first of the AD studies (Sano 1996) the authors reported some benefit from vitamin E (2000 IU/day) with fewer participants reaching an end point of death, institutionalisation, change to a Clinical Dementia Rating (CDR) of three, or loss of two basic activities of daily living within two years. Of patients completing treatment, 58% (45/77) on vitamin E compared with 74% (58/78) on placebo reached one of the end points (odds ratio (OR) 0.49; 95% confidence interval (CI) 0.25 to 0.96). The second AD treatment study (Lloret 2009) explored the effects of vitamin E (800 IU/day) on cognitive progression in relation to oxidative stress levels. Patients whose oxidative stress markers were lowered by vitamin E showed no significant difference in the percentage change in Mini-Mental State Examination (MMSE) score, between baseline and six months, compared to the placebo group. The primary aim of the MCI study (Petersen 2005) was to investigate the effect of vitamin E (2000 IU/day) on the time to progression from MCI to possible or probable AD. A total of 214 of the 769 participants progressed to dementia, with 212 being classified as having possible or probable AD. There was no significant difference in the probability of progression from MCI to AD between the vitamin E group and the placebo group (hazard ratio 1.02; 95% CI 0.74 to 1.41; P = 0.91)., Authors' Conclusions: No convincing evidence that vitamin E is of benefit in the treatment of AD or MCI. Future trials assessing vitamin E treatment in AD should not be restricted to alpha-tocopherol.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results